Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707265 · ClinicalTrials.gov registry record · Phase 3
rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study
A Phase 3 study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- Phase 3
- Development phase
- 463
- Enrollment target
NCT00707265 is a Phase 3 study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 463 participants.
The verdict
NCT00707265, a Phase 3 study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 463 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the rhBMP-2/CRM/CD HORIZON® Spinal System as a method of facilitating spinal fusion in patients with degenerative disc disease.
Interventions
- DEVICE rhBMP-2/CRM/CD HORIZON® Spinal System
- DEVICE Autograft/CD HORIZON® Spinal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2002-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707265
The ClinicalTrials.gov registry entry for NCT00707265 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 463 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rhBMP-2/CRM/CD HORIZON® Spinal System is the first listed.
NCT00707265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707265 about?
NCT00707265 is a clinical study titled "rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study". The purpose of this study was to evaluate the rhBMP-2/CRM/CD HORIZON® Spinal System as a method of facilitating spinal fusion in patients with degenerative disc disease.
What is the current status of trial NCT00707265?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 463 participants. The study started on 2002-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00707265?
The interventions under investigation include: rhBMP-2/CRM/CD HORIZON® Spinal System (DEVICE), Autograft/CD HORIZON® Spinal System (DEVICE).
Who is sponsoring clinical trial NCT00707265?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.